Skip to search.
 TSX Up 0.26% TSX Ventures Up 0.38%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
18.25 Up 0.62(3.52%) 2:58PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:17.63
Open:17.95
Bid:18.08 x 100
Ask:18.10 x 100
1y Target Est:26.50
Beta:0.073269
Earnings Date:Nov 5 - Nov 9 (Est.)
Day's Range:17.73 - 18.25
52wk Range:11.87 - 23.67
Volume:96,052
Avg Vol (3m):192,009
Market Cap:628.52M
P/E (ttm):161.50
EPS (ttm):0.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OSIRUp 3.52%628.52M
BIIBUp 3.22%71.00B
ABTUp 0.46%65.24B

Key Statistics

Forward P/E (1 yr):39.30
P/S (ttm):7.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.21
Quarterly EPS Est (Sep-15) :0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback